Colgate-Palmolive (NYSE:CL – Get Free Report) had its price target decreased by stock analysts at JPMorgan Chase & Co. from $109.00 to $103.00 in a research note issued on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 17.18% from the stock’s previous close.
A number of other research analysts also recently weighed in on the company. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their target price for the company from $105.00 to $101.00 in a research note on Monday, October 28th. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $103.05.
View Our Latest Research Report on CL
Colgate-Palmolive Trading Up 0.3 %
Insiders Place Their Bets
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.37% of the company’s stock.
Institutional Investors Weigh In On Colgate-Palmolive
Large investors have recently added to or reduced their stakes in the stock. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive in the third quarter valued at about $53,000. Prospera Private Wealth LLC bought a new stake in Colgate-Palmolive during the third quarter worth about $64,000. True Wealth Design LLC grew its stake in Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after buying an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC increased its holdings in Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after buying an additional 368 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Most active stocks: Dollar volume vs share volume
- 3 Cheap Small-Cap Banks for Dividend Growth Investors
- Investing in Commodities: What Are They? How to Invest in Them
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- Golden Cross Stocks: Pattern, Examples and Charts
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.